- Home
- QUBT vs MANE Comparison
QUBT vs MANE Comparison
Compare QUBT & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QUBT | MANE |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | QUBT | MANE |
|---|---|---|
| Price | $6.80 | $65.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $17.00 | ★ $78.33 |
| AVG Volume (30 Days) | ★ 9.2M | 303.8K |
| Earning Date | 03-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $682,000.00 | N/A |
| Revenue This Year | $3,210.56 | N/A |
| Revenue Next Year | $51.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 82.84 | N/A |
| 52 Week Low | $5.76 | $36.26 |
| 52 Week High | $25.84 | $69.41 |
Technical Indicators
Market Signals| Indicator | QUBT | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 74.51 |
| Support Level | N/A | $39.73 |
| Resistance Level | $9.15 | N/A |
| Average True Range (ATR) | 0.39 | 4.67 |
| MACD | 0.04 | 0.92 |
| Stochastic Oscillator | 3.97 | 82.48 |
Price Performance
Historical ComparisonAbout QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.